Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.

Lima JF, Oliveira LM, Pereira NZ, Duarte AJ, Sato MN.

Sci Rep. 2017 Apr 3;7(1):524. doi: 10.1038/s41598-017-00637-3.

2.

HIV-1 prophylactic vaccines: state of the art.

Lelièvre JD, Lévy Y.

J Virus Erad. 2016 Jan 1;2(1):5-11. Review.

3.

Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.

Cervantes CA, Oliveira LM, Manfrere KC, Lima JF, Pereira NZ, Duarte AJ, Sato MN.

Sci Rep. 2016 May 11;6:25875. doi: 10.1038/srep25875.

4.

Prevention of SHIV transmission by topical IFN-β treatment.

Veazey RS, Pilch-Cooper HA, Hope TJ, Alter G, Carias AM, Sips M, Wang X, Rodriguez B, Sieg SF, Reich A, Wilkinson P, Cameron MJ, Lederman MM.

Mucosal Immunol. 2016 Nov;9(6):1528-1536. doi: 10.1038/mi.2015.146. Epub 2016 Feb 3.

5.

Serum protein electrophoresis under effective control of HIV-1 disease progression.

Adedeji AL, Adenikinju RO, Ajele JO, Olawoye TL.

EXCLI J. 2014 Jul 15;13:761-71. eCollection 2014.

6.

Increased frequency of circulating Tc22/Th22 cells and polyfunctional CD38(-) T cells in HIV-exposed uninfected subjects.

Oliveira LM, Lima JF, Cervantes CA, Casseb JS, Mendonça M, Duarte AJ, Sato MN.

Sci Rep. 2015 Sep 8;5:13883. doi: 10.1038/srep13883.

7.

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.

Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, Leadabrand KS, Milush JM, York VA, Raposo RA, Cheng RG, Eriksson EM, McMahan V, Glidden DV, Shiboski S, Grant RM, Nixon DF, Kallás EG.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8379-84. doi: 10.1073/pnas.1501443112. Epub 2015 Jun 22.

8.

p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individuals.

Herbeck J, Ghorai S, Chen L, Rinaldo CR, Margolick JB, Detels R, Jacobson L, Wolinsky S, Mullins JI.

PLoS One. 2015 Mar 6;10(3):e0119218. doi: 10.1371/journal.pone.0119218. eCollection 2015.

9.

Immunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2).

Li X, Zhang K, Pajewski NM, Brill I, Prentice HA, Shrestha S, Kilembe W, Karita E, Allen S, Hunter E, Kaslow RA, Tang J.

Genes Immun. 2015 Apr-May;16(3):213-20. doi: 10.1038/gene.2014.84. Epub 2015 Jan 29.

10.

Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Hill BJ, Darrah PA, Ende Z, Ambrozak DR, Quinn KM, Darko S, Gostick E, Wooldridge L, van den Berg HA, Venturi V, Larsen M, Davenport MP, Seder RA, Price DA, Douek DC.

J Immunol. 2014 Dec 1;193(11):5626-36. doi: 10.4049/jimmunol.1401017. Epub 2014 Oct 27.

11.

Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition.

An P, Goedert JJ, Donfield S, Buchbinder S, Kirk GD, Detels R, Winkler CA.

J Infect Dis. 2014 Nov 15;210(10):1539-48. doi: 10.1093/infdis/jiu291. Epub 2014 May 19.

12.

Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States.

Scott HM, Vittinghoff E, Irvin R, Sachdev D, Liu A, Gurwith M, Buchbinder SP.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):115-21. doi: 10.1097/QAI.0b013e3182a98bae.

13.

A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.

Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).

Hum Mol Genet. 2013 May 1;22(9):1903-10. doi: 10.1093/hmg/ddt033. Epub 2013 Jan 30.

14.

Host genomic influences on HIV/AIDS.

O'Brien SJ, Hendrickson SL.

Genome Biol. 2013 Jan 31;14(1):201. doi: 10.1186/gb-2013-14-1-201. Review.

15.

SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations.

Ma D, Jasinska A, Kristoff J, Grobler JP, Turner T, Jung Y, Schmitt C, Raehtz K, Feyertag F, Martinez Sosa N, Wijewardana V, Burke DS, Robertson DL, Tracy R, Pandrea I, Freimer N, Apetrei C; International Vervet Research Consortium.

PLoS Pathog. 2013 Jan;9(1):e1003011. doi: 10.1371/journal.ppat.1003011. Epub 2013 Jan 17.

16.

Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier.

Nakagawa S, Castro V, Toborek M.

J Cell Mol Med. 2012 Dec;16(12):2950-7. doi: 10.1111/j.1582-4934.2012.01622.x.

17.

Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1.

Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, Essex M, McElrath MJ, Nakku-Joloba E, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2012 Oct;206(8):1299-308. Epub 2012 Aug 27.

18.

Risk of HIV Infection and Lethality Are Decreased in CCR5del32  Heterozygotes: Focus Nosocomial Infection Study and Meta-analysis.

Borinskaya SA, Kozhekbaeva ZhM, Zalesov AV, Olseeva EV, Maksimov AR, Kutsev SI, Garaev MM, Rubanovich AV, Yankovsky NK.

Acta Naturae. 2012 Jan;4(1):42-52.

19.

HIV controllers: a multifactorial phenotype of spontaneous viral suppression.

Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE.

Clin Immunol. 2011 Oct;141(1):15-30. doi: 10.1016/j.clim.2011.07.007. Epub 2011 Aug 4. Review.

20.

Immunodeficiency lentiviral infections in natural and non-natural hosts.

Brenchley JM, Paiardini M.

Blood. 2011 Jul 28;118(4):847-54. doi: 10.1182/blood-2010-12-325936. Epub 2011 Apr 19. Review.

Supplemental Content

Support Center